Company / Working Capital per Share
Janux Therapeutics, Inc. Working Capital per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$15.35
FY2025
5-year range
$7.62 / $18.91
FY2021-FY2025
Trend
-18.8%
vs FY2024
Sector context
#27 of 212
Health Care
What the data says
Janux Therapeutics, Inc.'s working capital per share of $15.35 is higher than 87% of companies in the Health Care sector (FY2025). Working Capital per Share has fluctuated over the past 6 years, ranging from $7.62 in FY2022 to $18.91 in FY2024.
Based on SEC 10-K filings.
15.35 in FY2025 with a 5-year CAGR of +1.7%. Top quartile in the Health Care sector.
Improved from $7.64 to $15.35 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +26.3%
- 5-Year CAGR
- +1.7%
- 10-Year CAGR
- -
Sector benchmark
-86.9% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 18.8% year-over-year.
- Ranks #27 out of 212 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2024.
- Lowest working capital per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 9.17 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.35 | -18.8% |
| FY2024 | $18.91 | +147.5% |
| FY2023 | $7.64 | +0.3% |
| FY2022 | $7.62 | -50.8% |
| FY2021 | $15.48 | +10.0% |
| FY2020 | $14.08 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026